Divided attention is a critical cognitive function that enables individuals to manage multiple tasks simultaneously, a skill increasingly relevant in modern environments saturated with distractions. While acetylcholine has long been recognized as a key neuromodulator supporting attentional processes, the specific contributions of muscarinic receptor subtypes remain poorly understood. This study investigates the role of M1 and M4 muscarinic receptors in divided attention using a novel operant task in male Sprague-Dawley rats. The task integrates high-response-rate auditory sustained attention with an unpredictable visual distractor task, allowing for precise assessment of performance under dual-task conditions. Systemic administration of scopolamine, a nonselective muscarinic antagonist, impaired performance on both sustained and divided attention tasks, reducing accuracy and increasing trial duration. Subsequent experiments targeted subtype-specific antagonists: telenzepine (M1-preferring) and tropicamide (M4-preferring). Telenzepine significantly disrupted divided attention performance without affecting the primary sustained attention task, indicating a selective role for M1 receptors in managing concurrent cognitive demands. In contrast, tropicamide had no effect on either task, suggesting minimal involvement of M4 receptors in this domain. Behavioral analysis revealed that engagement with the distractor task reduced accuracy in the main auditory task, further supporting the notion that M1-mediated mechanisms are crucial for maintaining focus during divided attention. These findings provide strong evidence that M1, but not M4, muscarinic receptors play a pivotal role in divided attention, highlighting their potential as therapeutic targets for cognitive enhancement in disorders characterized by attentional deficits.
The design of the experimental paradigm was instrumental in isolating the effects of pharmacological agents on divided attention. By requiring rats to perform variable-ratio lever pressing sequences while occasionally encountering a secondary nosepoke task, the model mimics real-world multitasking scenarios where attention must be flexibly allocated between competing stimuli. The use of palatable sucrose pellets as reinforcement for the distractor task ensured motivation and ecological validity. Scopolamine’s broad impairment across both tasks confirmed the cholinergic system’s fundamental role in attention, consistent with prior literature. However, the differential impact of telenzepine—specifically impairing performance only during divided attention—suggests that M1 receptors are uniquely involved in integrating information across modalities or suppressing irrelevant inputs during task switching. This finding aligns with neuroanatomical data showing dense M1 expression in cortical regions associated with executive control and sensory integration. Notably, telenzepine produced fewer nonspecific effects compared to scopolamine, such as reduced overall responding or motor slowing, underscoring its potential as a more selective probe for cognitive functions. In contrast, tropicamide’s lack of effect, despite previous reports of M4 involvement in motor control, supports the conclusion that M4 receptors are not central to attentional processing in this context. The absence of interaction between drug dose and task type further confirms that the observed deficits were not due to general cognitive or motivational impairments but rather to a specific disruption of attentional allocation mechanisms.
These results have significant implications for the development of cognitive enhancers targeting muscarinic receptors. Given that M1 agonists and positive allosteric modulators show promise in treating cognitive symptoms in Alzheimer’s disease and schizophrenia, identifying their specific contribution to divided attention strengthens their clinical relevance.Mucin-1/MUC1 ProteinMolecular Weight The current findings suggest that interventions aimed at enhancing M1 receptor activity could improve multitasking abilities, particularly in situations requiring rapid switching between tasks or filtering out distractions.SMARCC1 Antibody Autophagy Furthermore, the dissociation between M1 and M4 roles underscores the importance of subtype selectivity in drug design—nonselective muscarinic agents may produce unwanted side effects due to off-target activation or blockade.PMID:34856050 Future research should explore whether M1 modulation affects other aspects of executive function, such as working memory updating or inhibitory control, and whether these effects are modulated by hormonal states, given the known influence of estrogen via GPR30 on cholinergic tone. Overall, this study provides compelling evidence that the M1 muscarinic receptor is a critical mediator of divided attention, offering a clear path forward for targeted therapeutic strategies.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com
